Congress’ push to rein in drug costs will impact benefit strategies

By Alyssa Place, This is my expertise
Published 3 Min Read

Exterior of US capitol building
Bloomberg

  • What’s at Stake: Rising pharmacy costs threaten the sustainability of employer-sponsored health coverage.  
  • Supporting Data: Employer-sponsored coverage insures more than 150 million Americans.  
  • Forward Look: Expect transparency, competition, and contracting reforms to reshape employer pharmacy strategies.
  • Source: Bullets generated by AI with editorial review

As prescription drug spending continues to climb, employer groups are pressing lawmakers to go beyond surface-level reforms and address structural inefficiencies embedded throughout the drug supply chain.

Alyssa Place
Editor-in-chief

Alyssa Place is the editor-in-chief of Employee Benefit News and has been with the team since 2019. Her work covers mental health, DEI, women at work, financial wellness, retirement and workplace … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form